Abstract

Summary

This thesis reveals that sleep and circadian disruption in diabetes stems from dysfunctional rod inputs to melanopsin-containing retinal ganglion cells, while in Parkinson's disease the dysfunction occurs at the melanopsin ganglion cell level itself with additional reductions in retinal contrast gain. These findings suggest that lighting interventions for diabetic or Parkinsonian patients may need to account for compromised photoreceptor pathways, potentially requiring higher light intensities or adjusted spectral content to achieve adequate circadian entrainment.
Abstract

Key Findings

  • In diabetes, dysfunctional outer retinal rod inputs to melanopsin ganglion cells are identified as a key contributor to sleep disruption.
  • In Parkinson's disease, melanopsin ganglion cell dysfunction is the primary locus of circadian disruption, accompanied by non-selective reductions in retinal contrast gain.
  • Two distinct retinal pathways are implicated in disease-related circadian disruption: rod-to-melanopsin cell signaling (diabetes) versus intrinsic melanopsin cell dysfunction (Parkinson's disease).
Categories

Categories

Sleep & Circadian Health: Investigates retinal photoreceptor pathways underlying circadian disruption and sleep problems in systemic disease.
The Science of Light: Identifies specific retinal cell types (rods, melanopsin ganglion cells) and their roles in photoentrainment and sleep regulation.
Dementia & Elder Care: Examines Parkinson's disease-related circadian disruption linked to melanopsin ganglion cell dysfunction.
Authors

Author(s)

S Dumpala
Publication Date

Publication Year

2020
View more publications